Skip to main content

Advertisement

Log in

Efficacy of Intranasal Dexmedetomidine for Conscious Sedation in Patients Undergoing Surgical Removal of Impacted Third Molar: A Double-Blind Split Mouth Study

  • Research Paper
  • Published:
Journal of Maxillofacial and Oral Surgery Aims and scope Submit manuscript

Abstract

Background

This study was conducted to evaluate the utility and effectiveness of Intranasal Dexmedetomidine on Sedation status and pain experience of the patients undergoing surgical extraction of impacted third molar.

Materials and Methods

In this double-blind, split mouth study, in 15 patients, evaluations pertaining to classes of third molar impaction was done. Each patient was randomly assigned to receive either intranasal normal saline (placebo group) or intranasal 1.5 µg/kg atomized Dexmedetomidine during the first session. The other regimen was used during the second session. Study was conducted for over a period of 120 min and data for sedation and pain was collected at an interval of 30 min. The collected data was then compared between the two groups within the same patient. Sedation status was assessed by a blinded observer with a modified Observer’s Assessment of Alertness/Sedation (OAA/S) 13 scale (Annexure- B). Pain experience was evaluated by Visual Analog Scale (VAS) (Annexure-B). Clinical evaluation for sedation and pain was done by a blinded observer at 30, 60, 90, and 120 min after administration of the intranasal solution. The values were then tabulated, and compared between two visits.

Results

The mean values of OAA score of Dexmedetomidine group were significantly higher as compared to Placebo group with a ‘p’ value of 0.000. And the mean values of Pain score of Dexmedetomidine group were significantly lower as compared to Placebo group with a ‘p’ value 0.009.

Conclusion

The results of this study clearly indicated that: Intranasally administered Dexmedetomidine was significantly useful and effective to achieve optimal sedation and analgesia during third molar surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Graph 1
Graph 2
Fig. 3

Similar content being viewed by others

References

  1. Kazim K, Fahrettin Y, Nebahat G, Cemil C, Murat S, Hasan K (2007) Comparision of Dexmedetomidine and Midazolam for monitored anesthesia care with tramadol via patient controlled analgesia in endoscopic nasal surgery: a prospective, randomized, double blind, clinical study. Curr Ther Res 68(2):69–81

    Article  Google Scholar 

  2. Malamed SF (2003) Sedation: a guide to patient management, 4th edn, Mosby Inc, Missouri, pp 9–12, 23

  3. Merkus P, Ebbens FA, Muller B, Fokkens WJ (2006) The ‘best method’ of topical nasal drug delivery: comparison of seven techniques. Rhinology 44:102–107

    CAS  PubMed  Google Scholar 

  4. Afonso J, Reis F (2012) Dexmedetomidine: Current role in anesthesia and intensive care. Rev Bras Anestesiol 62(1):118–133

    Article  CAS  PubMed  Google Scholar 

  5. Taittonen MT, Kirvela OA, Aantaa R, Kanto JH (1997) Effect of clonidine and dexmedetomidine premedication on perioperative oxygen consumption and haemodynamic state. Br J Anaesth 78:400–406

    Article  CAS  PubMed  Google Scholar 

  6. Guler G, Akin A, Tosun E, Eskitafloglu E, Mizrak A, Boyaci A (2005) Single dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anaesthesiol Scand 49:1088–1091

    Article  CAS  PubMed  Google Scholar 

  7. Kaur M, Singh PM (2011) Current role of dexmedetomidine in clinical anesthesia and intensive care. Anesth Essays Res 5:128–133

    Article  PubMed  PubMed Central  Google Scholar 

  8. Warrington SE, Kuhn RJ (2011) Use of intranasal medications in pediatric patients. Pharmacol Update Orthop 34(6):456–459

    Google Scholar 

  9. Talon MD, Woodson LC, Sherwood ER, Aarsland A, McRae L, Benham T (2009) Intranasal dexmedetomidine premedication is comparable with midazolam in burn children undergoing reconstructive surgery. J Burn Care Res 30(4):599–605

    Article  PubMed  Google Scholar 

  10. Yuen VM, Hui TW, Irwin MG, Yuen MK (2008) A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial. Anesth Analg 106:1715–1721

    Article  CAS  PubMed  Google Scholar 

  11. Cheung CW, Ying CL, Chiu WK, Wong GT, Ng KF, Irwin MG (2007) A comparison of dexmedetomidine and midazolam for sedation in third molar surgery. Anaesthesia 62:1132–1138

    Article  CAS  PubMed  Google Scholar 

  12. Nooh N, Sheta SA, Abdullah WA, Abdelhalim AA (2013) Intranasal atomized dexmedetomidine for sedation during third molar extraction. Int J Oral Maxillofac 42:857–862

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Garima Aggarwal.

Ethics declarations

Conflict of interest

Dr. Sujeeth K. Shetty and Dr. Garima declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institution.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shetty, S.K., Aggarwal, G. Efficacy of Intranasal Dexmedetomidine for Conscious Sedation in Patients Undergoing Surgical Removal of Impacted Third Molar: A Double-Blind Split Mouth Study. J. Maxillofac. Oral Surg. 15, 512–516 (2016). https://doi.org/10.1007/s12663-016-0889-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12663-016-0889-3

Keywords

Navigation